US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 54.320
  • +2.460+4.74%
Close Nov 22 16:00 ET
  • 54.320
  • 0.0000.00%
Post 16:01 ET
3.43BMarket Cap-42771P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
232.23%43.11M
131.90%30.58M
53.27%19.82M
-16.81%54.12M
-9.99%15.03M
-12.14%12.98M
-25.30%13.19M
-18.89%12.93M
65.06M
16.7M
Selling and administrative expenses
36.81%7.38M
54.31%6.92M
23.38%6.81M
-3.00%22.32M
30.11%6.93M
-6.17%5.39M
-28.31%4.48M
0.53%5.52M
--23.01M
--5.33M
-General and administrative expense
36.81%7.38M
54.31%6.92M
23.38%6.81M
-3.00%22.32M
30.11%6.93M
-6.17%5.39M
-28.31%4.48M
0.53%5.52M
--23.01M
--5.33M
Research and development costs
371.13%35.74M
171.86%23.66M
75.51%13.01M
-24.37%31.8M
-28.77%8.1M
-15.95%7.59M
-23.65%8.7M
-29.08%7.42M
--42.05M
--11.37M
Operating profit
-232.23%-43.11M
-131.90%-30.58M
-53.27%-19.82M
16.81%-54.12M
9.99%-15.03M
12.14%-12.98M
25.30%-13.19M
18.89%-12.93M
-65.06M
-16.7M
Net non-operating interest income expense
Other net income (expense)
411.41%7.09M
599.95%5.9M
717.48%5.92M
1,613.34%10.14M
2,900.28%7.19M
3,587.69%1.39M
243.76%842.65K
941.05%723.59K
591.73K
239.51K
Gain on sale of security
95.20%-26.75K
-136.10%-39.29K
----
----
----
---557.14K
--108.84K
----
----
----
Other non- operating income (expenses)
266.17%7.12M
709.13%5.94M
717.48%5.92M
1,613.34%10.14M
2,784.83%6.91M
5,069.73%1.94M
199.35%733.81K
941.05%723.59K
--591.73K
--239.51K
Income before tax
-210.79%-36.02M
-99.95%-24.68M
-13.90%-13.91M
31.77%-43.98M
52.34%-7.84M
21.33%-11.59M
29.09%-12.34M
23.09%-12.21M
-64.47M
-16.46M
Income tax
218.45%92.11K
675.46%78.7K
538.07%70.25K
159.55%94.39K
302.36%44.31K
230.93%28.92K
9.34%10.15K
50.16%11.01K
36.37K
11.01K
Net income
-210.81%-36.11M
-100.42%-24.76M
-14.38%-13.98M
31.67%-44.08M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
-64.51M
-16.47M
Net income continuous Operations
-210.81%-36.11M
-100.42%-24.76M
-14.38%-13.98M
31.67%-44.08M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
---64.51M
---16.47M
Minority interest income
66.99%-724.09K
77.79%-491.74K
90.61%-301.87K
44.46%-8.07M
-170.37%-450.31K
52.64%-2.19M
58.19%-2.21M
-3.21M
-14.53M
639.89K
Net income attributable to the parent company
-275.45%-35.39M
-139.34%-24.27M
-51.85%-13.67M
27.95%-36.01M
56.53%-7.44M
6.77%-9.43M
16.35%-10.14M
43.29%-9M
-49.97M
-17.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-275.45%-35.39M
-139.34%-24.27M
-51.85%-13.67M
27.95%-36.01M
56.53%-7.44M
6.77%-9.43M
16.35%-10.14M
43.29%-9M
-49.97M
-17.11M
Basic earnings per share
-211.11%-0.56
-69.57%-0.39
4.35%-0.22
57.06%-0.73
67.74%-0.1
33.33%-0.18
32.35%-0.23
46.52%-0.23
-1.7
-0.31
Diluted earnings per share
-211.11%-0.56
-69.57%-0.39
4.35%-0.22
57.06%-0.73
67.74%-0.1
33.33%-0.18
32.35%-0.23
46.52%-0.23
-1.7
-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 232.23%43.11M131.90%30.58M53.27%19.82M-16.81%54.12M-9.99%15.03M-12.14%12.98M-25.30%13.19M-18.89%12.93M65.06M16.7M
Selling and administrative expenses 36.81%7.38M54.31%6.92M23.38%6.81M-3.00%22.32M30.11%6.93M-6.17%5.39M-28.31%4.48M0.53%5.52M--23.01M--5.33M
-General and administrative expense 36.81%7.38M54.31%6.92M23.38%6.81M-3.00%22.32M30.11%6.93M-6.17%5.39M-28.31%4.48M0.53%5.52M--23.01M--5.33M
Research and development costs 371.13%35.74M171.86%23.66M75.51%13.01M-24.37%31.8M-28.77%8.1M-15.95%7.59M-23.65%8.7M-29.08%7.42M--42.05M--11.37M
Operating profit -232.23%-43.11M-131.90%-30.58M-53.27%-19.82M16.81%-54.12M9.99%-15.03M12.14%-12.98M25.30%-13.19M18.89%-12.93M-65.06M-16.7M
Net non-operating interest income expense
Other net income (expense) 411.41%7.09M599.95%5.9M717.48%5.92M1,613.34%10.14M2,900.28%7.19M3,587.69%1.39M243.76%842.65K941.05%723.59K591.73K239.51K
Gain on sale of security 95.20%-26.75K-136.10%-39.29K---------------557.14K--108.84K------------
Other non- operating income (expenses) 266.17%7.12M709.13%5.94M717.48%5.92M1,613.34%10.14M2,784.83%6.91M5,069.73%1.94M199.35%733.81K941.05%723.59K--591.73K--239.51K
Income before tax -210.79%-36.02M-99.95%-24.68M-13.90%-13.91M31.77%-43.98M52.34%-7.84M21.33%-11.59M29.09%-12.34M23.09%-12.21M-64.47M-16.46M
Income tax 218.45%92.11K675.46%78.7K538.07%70.25K159.55%94.39K302.36%44.31K230.93%28.92K9.34%10.15K50.16%11.01K36.37K11.01K
Net income -210.81%-36.11M-100.42%-24.76M-14.38%-13.98M31.67%-44.08M52.10%-7.89M21.18%-11.62M29.07%-12.35M23.05%-12.22M-64.51M-16.47M
Net income continuous Operations -210.81%-36.11M-100.42%-24.76M-14.38%-13.98M31.67%-44.08M52.10%-7.89M21.18%-11.62M29.07%-12.35M23.05%-12.22M---64.51M---16.47M
Minority interest income 66.99%-724.09K77.79%-491.74K90.61%-301.87K44.46%-8.07M-170.37%-450.31K52.64%-2.19M58.19%-2.21M-3.21M-14.53M639.89K
Net income attributable to the parent company -275.45%-35.39M-139.34%-24.27M-51.85%-13.67M27.95%-36.01M56.53%-7.44M6.77%-9.43M16.35%-10.14M43.29%-9M-49.97M-17.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -275.45%-35.39M-139.34%-24.27M-51.85%-13.67M27.95%-36.01M56.53%-7.44M6.77%-9.43M16.35%-10.14M43.29%-9M-49.97M-17.11M
Basic earnings per share -211.11%-0.56-69.57%-0.394.35%-0.2257.06%-0.7367.74%-0.133.33%-0.1832.35%-0.2346.52%-0.23-1.7-0.31
Diluted earnings per share -211.11%-0.56-69.57%-0.394.35%-0.2257.06%-0.7367.74%-0.133.33%-0.1832.35%-0.2346.52%-0.23-1.7-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data